Head-to-Head

Arcosa, Inc. Common Stock vs. PROTO LABS, INC.

ACA

Arcosa, Inc. Common Stock

$144.90 -0.34%

VS PRLB

PROTO LABS, INC.

$79.61 +1.04%

Arcosa, Inc. Common Stock (ACA) comes out ahead, leading on 9 of 9 compared factors.

Size & Scale

ACAPRLB
Market Cap $7.12 billion $1.90 billion
Revenue (TTM) $2.74 billion $560.54 million
Net Income (TTM) $491.40 million $30.48 million

ACA leads on 3 of 3 size & scale factors.

Valuation

ACAPRLB
P/E Ratio 14.53 63.69
Price / Book 2.39 2.75
Price / Sales 2.59 3.40

ACA leads on 3 of 3 valuation factors.

Profitability

ACAPRLB
Net Margin 17.90% 5.44%
Return on Equity 16.47% 4.41%

ACA leads on 2 of 2 profitability factors.

Dividend

ACAPRLB
Dividend Yield 0.14% —
Payout Ratio 2.01 —

ACA and PRLB split the dividend factors evenly.

Risk & Sentiment

ACAPRLB
Short Interest 2.16% 11.02%

ACA leads on 1 of 1 risk & sentiment factors.

Dig deeper: ACA overview, ACA financials, PRLB overview, PRLB financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.